Immix Biopharma, Inc.
Immix Biopharma, Inc. (IMMX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
immx · stock forecast · 4 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$20.00
Consensus
$17.00
+116.0% upside
Low
$14.00
Median: $17 · Last Close: $7.87
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$17.00
116.0% upside
High Target
$20
154.1%
Low Target
$14
77.9%
Current Price
$7.87
as of today
Based on analyst price targets, the IMMX stock price prediction for the next 12 months ranges from $14 to $20. The consensus IMMX price forecast of $17.00 implies 116.0% upside from the current price of $7.87.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $7.48 | ↓ 5.00% |
1-day model range: $7.42–$7.54. Peak: $7.54 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $8 | +1.1% |
| 2028 | $8 | +1.7% |
| 2029 | $8 | +2.0% |
| 2030 | $8 | +2.2% |
| 2031 | — | +2.3% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IMMX · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-30 | Mizuho | Maintains | Outperform→Outperform |
| 2026-03-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-27 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-12-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Immix Biopharma, Inc. (IMMX) stock. Of the recent 16 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover IMMX.
Analyst Recommendation Trends
IMMX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$12M
↓ 94.1% YoY
Revenue Next Year
$56M
↑ 364.7% YoY
EPS This Year
$-0.70
EPS Next Year
$-0.65
↓ 7.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast IMMX EPS of $-0.70 for the current fiscal year, based on estimates from 4 analysts. The IMMX revenue forecast is $12M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The IMMX stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus IMMX price target is $17.00 (+116.0% upside), with an analyst consensus of Buy.
The IMMX short-term stock prediction for tomorrow is $7.48 (-5.00%). The IMMX stock price prediction for 2027 estimates an average of $8. The IMMX stock prediction for 2030 projects a range of $7–$9.
Immix Biopharma, Inc. trades on NASDAQ under the ticker IMMX. The IMMX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
IMMX forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month IMMX price target is $17.00, with a high forecast of $20.00 and a low of $14.00. The median price target is shown in the chart above when available. This implies +116.0% potential upside from the current price of $7.87.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.